Usefulness of bone-specific alkaline phosphatase in the detection of bone metastases in prostate cancer;Utilidad de la fosfatasa alcalina ósea en la detección de metástasis óseas en cáncer de próstata

Archivos Espanoles de Urologia

Volumn 57, Issue 7, 2004, Pages 693-698

  Muñoz, Alfonso Rasch Isla ^a   Cataño, Juan Guillermo Cataño ^a  

^a HOSPITAL UNIVERSITARIO SAN IGNACIO   (Colombia)

Author keywords

Bone metastases; Bone scan; Bone specific alkaline phosphatase; Prostate cancer

Indexed keywords

ALKALINE PHOSPHATASE;

ADENOCARCINOMA; AGED; ARTICLE; BLOOD; BONE TUMOR; HUMAN; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; SCINTISCANNING;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 16544363632     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. MOROTE, J.; LORENTE, J.; ENCABO, G.: "Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen." Cancer 78; 2374: 1998.
2. SMITH, J.; LANGE, P.; JANKNEGT, R. y cols.: "Serum markers as a predictor of response duration, and patient survival after hormonal theraphy for metastasic carcinoma of the prostate." J. Urol. 157; 1329: 1998.
3. LORENTE, J.; VALENZUELA, H.; MOROTE, J. y cols.: "Serum, bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients." Eur. J. Nucl. Med. 26; 625: 1997.
4. RAVENTOS, C.; LORENTE, J.; ENCABO, G. y cols.: "Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in detection of metastasis in prostate cancer." J. Urol. 155; 1348:1996.
5. STOKKEL, M.; ZWINDERMAN, A.; ZWARTENDIJK, J. y cols.: "The value of pretreatment clinical and biochemical parameters in patients with newly diagnosed untreated prostate carcinoma and no indications for bone metastases on the bone scintigram." Eur. J. Nucl. Med. 24; 1215:1997.
6. NAKASHIMA, J.; CHOICHIRO, O.; NISHIYAMA, T. y cols.: "Prognostic value of alkaline phosphatase flare in patientes with metastasic prostate cancer treated with endocrine therapy." Urology 56;843: 2000.
7. BERRUTI, A.; DOGLIOTTI, L.; BITOSSI, R. y cols.: "Incidence of skeletal complications in patients with bone metastasic prostate cancer and hormone refractory disease: predcitive role of bone resorption and formation markers evaluated at baseline." J. Urol. 164; 1248:2000.
8. PELGER, R.; LYCKLAMA A NIJEHOLT, G. y cols.: "The flare in serum alkaline phosphatase activity after orchiectomy: a valuable negative prognostic index por progression-free survival in prostatic carcinoma." J. Urol. 156;122. 1996.
9. MAGNUSSON, P.; LARSSON, L.; ENGLUND, G. y cols.: "Differences of bone alkaline phosphatase isoforms in metastasic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain." Clin. Chem. 44; 1621:1998.
10. CHEN, S.; CHEN, K.; LIN, A. y cols.: "The significance of serum alkaline phosphatase bone isoenzyme in prostatic cancer metastasis." Br. J. Urol. 79; 217. 1997.
11. CAJIGAS, J.; LATIFF, A.: "Cáncer de próstata (epidemiología y etiología). Revisión, crítica de la literatura." Urol. Colom. ÊIX; 7:2000.
12. WALSH, P.; RETIK, A.; DARRACOTT VAUGHAN, E. y cols.: "Campbell's Urology, 7th edition." Pags 2489-2496 y 2519-2537. W.B. Saunders company. Phipadelphia 1998.
13. TANAGHO, E.; McANINCH, J.: "Smith's General Urology. 15th edition." Págs 399-421. Lange medical books/Mc Graw-Hill. San Francisco 2000.
14. FLETCHER, R.; FLETCHER, S.; WAGNER, E.: "Clinical epidemiology. The essentials. 3rd edition." Williams&Wilkins. Boston 1996.